<< Back to Chromatin Club Home Page

Boston Epigenetic Society Seminar Series

Boston Epigenetic Society (BES)

The Boston Epigenetic Society has been founded to:

  • Promote epigenetics and epitranscriptomics
  • Foster research connections between academics and industry epigenetics scientists
  • Help promote new methods
  • Create a support system for experimental epigenetics research

The Society brings together both academic and industry partners all sharing a passion for epigenetics. Founding members represent the following institutions and companies: Accent Therapeutics, Alkermes, Astellas Pharma, AstraZeneca, Constellation Pharmaceuticals, Ring Therapeutics, Sanofi, Beth Israel Deaconess Medical School, Broad Institute, Harvard Medical School, Harvard University, Massachusetts General Hospital, University of Massachusetts Medical School

For more information about the organization and events, please visit and join the BES LinkedIn Group.

Attendance is free of charge, but registration is required.

Upcoming Event Details

Date: TBD

Time: TBD

Previous Event Details

Date: March 21, 2024

Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)

Featured Presenter:

  • Rong Fan Ph.D. – Professor, Dept. of Biomedical Engineering, Yale Univ
    Spatial Epigenome Sequencing for Mapping Tissue Function, Aging and Diseases

    Watch the Presentation

 

Date: February 29, 2024

Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)

Topic: Unlocking the Regulatory Genome: Pioneering RNA-Guided Therapeutics for Cell-State Modulation in Disease Pathogenesis

Featured Presenter:

 

Date: January 31, 2024

Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)

Topic: TBA

Featured Presenter:

  • Cigall Kadoch, Ph.D. – Associate Professor of Pediatric Oncology, Dana-Farber Cancer Center and Harvard Medical School; Scientific Founder, Foghorn Therapeutics
    Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Human Disease

 

Date: November 9, 2023

Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)

Topic: DNA: What is it Trying to Tell Us?

Featured Presenter:

  • Sir Shankar Balasubramanian, Ph.D. – Professor of Medicinal Chemistry, University of Cambridge

 

Date: September 21, 2023

Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)

Topic: Biology of NSD2 and Clinical Opportunities for KTX-1001, the First NSD2 Inhibitor to Enter the Clinic

Featured Presenters:

  • Terry Connolly, Ph.D. – CEO, K36 Therapeutics
  • Or Gozani, M.D., Ph.D. – Dr. Morris Herzstein Professor of Biology, Stanford University

 

Date: May 18, 2023

Time: 9:00 a.m. (PT) / 12:00 p.m. (ET)

Featured Presenter:

  • John Rinn, Ph.D. – Leslie Orgel Professor of RNA Science at University of Colorado, Boulder
    The Role of lncRNAs in Transcriptional Regulation

    Watch the Presentation